Fate Therapeutics (FATE) Other Non Operating Income (2012 - 2026)
Fate Therapeutics' Other Non Operating Income came in at $975,000 for Q2 2026, down 66.4% from $2.9 million a year earlier and down 45.4% from the prior quarter.
Powered by 
Analysis
Fate Therapeutics (FATE) Other Non Operating Income (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Fate Therapeutics reported Other Non Operating Income of $7.59 million, down 63.6% year-over-year; for FY2025, it came in at $11.39 million, down 52.6% from FY2024.
- Going back by year, Other Non Operating Income was $24.01 million in FY2024 (-18.8%), $29.58 million in FY2023 (+10.9%), $26.67 million in FY2022 (+450.6%) and $4.84 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Other Non Operating Income since Q4 2021.
- Year-over-year, Other Non Operating Income has declined for five consecutive quarters, with an average decline of 19.7% over the last eight quarters.
- The fastest year-over-year change in Other Non Operating Income over five years came in Q4 2022 (growth of 958.6%), and the weakest in Q4 2025 (a decline of 75.5%).
- Business Quant data shows FATE's Other Non Operating Income at $1.79 million (Q1 2026), $2.35 million (Q4 2025) and $2.49 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Fate Therapeutics | 276.57 Mn | 276.57 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 975,000.00 |
| Mar 31, 2026 | 1.79 Mn |
| Dec 31, 2025 | 2.35 Mn |
| Sep 30, 2025 | 2.49 Mn |
| Jun 30, 2025 | 2.90 Mn |
| Mar 31, 2025 | 3.66 Mn |
| Dec 31, 2024 | 9.60 Mn |
| Sep 30, 2024 | 4.70 Mn |
| Jun 30, 2024 | 6.66 Mn |
| Mar 31, 2024 | 3.06 Mn |
| Dec 31, 2023 | 3.95 Mn |
| Sep 30, 2023 | 6.11 Mn |
| Jun 30, 2023 | 9.81 Mn |
| Mar 31, 2023 | 9.71 Mn |
| Dec 31, 2022 | 8.06 Mn |
| Sep 30, 2022 | 2.83 Mn |
| Jun 30, 2022 | 7.00 Mn |
| Mar 31, 2022 | 8.78 Mn |
| Dec 31, 2021 | 761,000.00 |
| Sep 30, 2021 | 11.32 Mn |
API Access
Fate Therapeutics Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=FATE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();